Premium
Q32 Bio Inc (0T6G)
LSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | Institution | 4 127 987 | 24,34% | - | 2026-05-28 |
| Orbimed Private Investments VII, LP | Institution | 3 502 987 | 20,66% | - | 2026-05-28 |
| Atlas Venture Advisors, Inc. | Institution | 2 717 106 | 16,02% | - | 2026-05-28 |
| BVF Partners L.P. | Institution | 2 350 000 | 13,86% | - | 2026-06-04 |
| RA Capital Management, L.P. | Institution | 2 332 457 | 13,76% | - | 2026-05-28 |
| RA Capital Healthcare Fund, L.P. | Institution | 2 332 457 | 13,76% | - | 2026-05-28 |
| Opaleye Management Inc. | Institution | 1 256 228 | 7,41% | - | 2026-03-31 |
| Opaleye L.P | Institution | 1 256 228 | 7,41% | - | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1 231 449 | 7,26% | - | 2026-06-04 |
| Abingworth LLP | Institution | 1 102 741 | 6,50% | - | 2026-03-31 |
| Point72 Associates, LLC | Institution | 958 768 | 5,65% | - | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 929 003 | 5,48% | - | 2026-06-04 |
| Atlas Venture Fund X, L.P. | Institution | 864 261 | 5,10% | - | 2026-05-28 |
| Atlas Venture Opportunity Fund II, L.P. | Institution | 724 549 | 4,27% | - | 2026-05-28 |
| OrbiMed Genesis Master Fund, L.P. | Institution | 625 000 | 3,69% | - | 2026-05-28 |
| Atlas Venture Opportunity Fund I | Institution | 503 296 | 2,97% | - | 2026-05-28 |
| Arch Venture Partners, L.P. | Institution | 320 482 | 1,89% | - | 2026-03-31 |
| Acorn Bioventures | Institution | 315 052 | 1,86% | - | 2026-03-31 |
| Sanofi | Institution | 244 083 | 1,44% | - | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 155 156 | 0,92% | - | 2026-06-04 |
| Monimus Capital Management, LP | Institution | 134 310 | 0,79% | - | 2026-03-31 |
| Pfizer Venture Investments LLC | Institution | 101 618 | 0,60% | - | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 49 995 | 0,29% | - | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 42 346 | 0,25% | - | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 35 000 | 0,21% | - | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 27 777 | 0,16% | - | 2026-03-31 |
| UBS Asset Management AG | Institution | 270 | 0,00% | - | 2026-03-31 |
| Bank of America Corporation | Institution | 0 | 0,00% | - | 2026-03-31 |
| JPMorgan Chase & Co. | Institution | 0 | 0,00% | - | 2026-03-31 |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | Institution | 0 | 0,00% | - | 2026-03-31 |
| Hudson River Trading LLC | Institution | 0 | 0,00% | - | 2026-03-31 |
| XTX Markets Limited | Institution | 0 | 0,00% | - | 2026-03-31 |
| Scientech Research LLC | Institution | 0 | 0,00% | - | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
